{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:18:17Z","timestamp":1787930297559,"version":"build-2784847793"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,14]]},"DOI":"10.7759\/cureus.103611","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T01:45:13Z","timestamp":1771119913000},"source":"Crossref","is-referenced-by-count":1,"title":["Assessing the Acceptance of and Compliance With Centchroman Usage, a Non-hormonal Contraceptive Pill, Among Postpartum Women: A Cross-Sectional Study at a Tertiary Care Centre in North India"],"prefix":"10.7759","author":[{"given":"Pooja","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Aparna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragati","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidushi","family":"Kulshrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Karna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Ministry of Health and Family Welfare, Government of India. National Family Planning Programme. National Health Mission.. (2025). Accessed: January 29, 2026: https:\/\/nhm.gov.in\/index1.php?lang=1&level=2&sublinkid=821&lid=222."},{"key":"ref2","unstructured":"Ministry of Health and Family Welfare, Government of India. Family Planning Division. India\u2019s Vision FP 2020. (2014). Accessed: January 29, 2026: https:\/\/advancefamilyplanning.org\/sites\/default\/files\/resources\/FP2020-Vision-Document%20India.pdf."},{"key":"ref3","unstructured":"Family Planning Division, Ministry of Health and Family Welfare, Government of India. Reference Manual for Oral Contraceptive Pills. (2015). Accessed. January 8, 2026: https:\/\/nhm.gov.in\/images\/pdf\/programmes\/family-planing\/guidelines\/Reference_Manual_Oral_Pills.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030373","article-title":"Scoping review to map evidence on mechanism of action, pharmacokinetics, effectiveness and side effects of centchroman as a contraceptive pill","volume":"9","author":"Kabra R","year":"2019","unstructured":"Kabra R, Allagh KP, Ali M, Jayathilaka CA, Mwinga K, Kiarie J. Scoping review to map evidence on mechanism of action, pharmacokinetics, effectiveness and side effects of centchroman as a contraceptive pill. BMJ Open. 2019, 9:e030373. 10.1136\/bmjopen-2019-030373","journal-title":"BMJ Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2741\/e807","article-title":"Centchroman: A safe reversible postcoital contraceptive with curative and prophylactic activity in many disorders","volume":"10","author":"Kamboj VP","year":"2018","unstructured":"Kamboj VP, Ray S, Anand N. Centchroman: A safe reversible postcoital contraceptive with curative and prophylactic activity in many disorders. Front Biosci (Elite Ed). 2018, 10:1-14. 10.2741\/e807","journal-title":"Front Biosci (Elite Ed)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/med.1011","article-title":"Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders","volume":"21","author":"Singh MM","year":"2001","unstructured":"Singh MM. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med Res Rev. 2001, 21:302-47. 10.1002\/med.1011","journal-title":"Med Res Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20203322","article-title":"A study to compare acceptability, safety and continuation rates of combined hormonal pill and centchroman as post abortion contraceptives","volume":"23","author":"Miuli I","year":"2020","unstructured":"Miuli I, Dewan R, Agarwal K. A study to compare acceptability, safety and continuation rates of combined hormonal pill and centchroman as post abortion contraceptives. Int J Reprod Contracept Obstet Gynecol. 2020, 23:3350-9. 10.18203\/2320-1770.ijrcog20203322","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04388.x","article-title":"Excretion of centchroman in breast milk","volume":"38","author":"Paliwal JK","year":"1994","unstructured":"Paliwal JK, Grover PK, Asthana OP, Nityanand S, Gupta RC. Excretion of centchroman in breast milk. Br J Clin Pharmacol. 1994, 38:485-6. 10.1111\/j.1365-2125.1994.tb04388.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20194594","article-title":"A study of Centchroman users with special reference to its contraceptive benefit","volume":"23","author":"Doke G","year":"2019","unstructured":"Doke G, Kamda J. A study of Centchroman users with special reference to its contraceptive benefit. Int J Reprod Contracept Obstet Gynecol. 2019, 23:4204-7. 10.18203\/2320-1770.ijrcog20194594","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref10","article-title":"A prospective study of centchroman users with special reference to its contraceptive benefit","volume":"6","author":"Nair H","year":"2016","unstructured":"Nair H, Jayasimhan P. A prospective study of centchroman users with special reference to its contraceptive benefit. J Evid Based Med Healthc. 2016, 6:5374-80.","journal-title":"J Evid Based Med Healthc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20205769","article-title":"Comparison of centchroman and PPIUCD in terms of efficacy, safety and continuation rate in immediate postpartum period","volume":"10","author":"Gupta M","year":"2021","unstructured":"Gupta M, Bansiwal R, Anand HP. Comparison of centchroman and PPIUCD in terms of efficacy, safety and continuation rate in immediate postpartum period. Int J Reprod Contracept Obstet Gynecol. 2021, 10:203-6. 10.18203\/2320-1770.ijrcog20205769","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(95)00214-u","article-title":"Centchroman: a new non-steroidal oral contraceptive in human milk","volume":"52","author":"Gupta RC","year":"1995","unstructured":"Gupta RC, Paliwal JK, Nityanand S, Asthana OP, Lal J. Centchroman: a new non-steroidal oral contraceptive in human milk. Contraception. 1995, 52:301-5. 10.1016\/0010-7824(95)00214-u","journal-title":"Contraception"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2023.109961","article-title":"Evaluation of acceptability, safety, and continuation rates of centchroman as postabortion nonsteroidal contraceptive pill","volume":"121","author":"Agarwal K","year":"2023","unstructured":"Agarwal K, Dewan R. Evaluation of acceptability, safety, and continuation rates of centchroman as postabortion nonsteroidal contraceptive pill. Contraception. 2023, 121:109961. 10.1016\/j.contraception.2023.109961","journal-title":"Contraception"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.36106\/ijsr\/5606595","article-title":"Clinical study of centchroman for its contraceptive benefits","volume":"12","author":"Sarmalkar M","year":"2023","unstructured":"Sarmalkar M, Chatterjee M, Mehendale M. Clinical study of centchroman for its contraceptive benefits. Int J Sci Res. 2023, 12:14-16. 10.36106\/ijsr\/5606595","journal-title":"Int J Sci Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20222797","article-title":"QI initiative to improve utilization of centchroman: a non-steroidal contraceptive","volume":"11","author":"Radhika AG","year":"2022","unstructured":"Radhika AG, Suneja A, Malik H, Gupta R. QI initiative to improve utilization of centchroman: a non-steroidal contraceptive. Int J Reprod Contracept Obstet Gynecol. 2022, 11:3068-73. 10.18203\/2320-1770.ijrcog20222797","journal-title":"Int J Reprod Contracept Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/451199-assessing-the-acceptance-of-and-compliance-with-centchroman-usage-a-non-hormonal-contraceptive-pill-among-postpartum-women-a-cross-sectional-study-at-a-tertiary-care-centre-in-north-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T01:45:15Z","timestamp":1771119915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/451199-assessing-the-acceptance-of-and-compliance-with-centchroman-usage-a-non-hormonal-contraceptive-pill-among-postpartum-women-a-cross-sectional-study-at-a-tertiary-care-centre-in-north-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.103611","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,14]]}}}